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Effects of enhanced oxygen release from hemoglobin by RSR13 Ischemic acute renal failure (ARF) often occurs in
in an acute renal failure model. hospitalized patients whose renal function has already
Background. Acute renal failure is believed to be caused, been diminished, for example, by disease or by aging.
in some circumstances, by impaired oxygen delivery to the
In addition, the use of nonsteroidal anti-inflammatoryouter medulla. This study examined the effect of RSR13, a
drugs (NSAIDs) as well as decreased circulating bloodsynthetic allosteric modifier of hemoglobin oxygen-binding af-
volume [vomiting, diarrhea, blood loss, poor nutritionfinity, on renal function in a setting of acute renal failure in
rats. (especially in the elderly), etc.] is often an associated if
Methods. An in vivo model of acute renal failure in the not a contributing factor to renal dysfunction. In the
rat produced by reduced renal mass, salt restriction, volume presence of these conditions, the use of radiocontrast
depletion, prostaglandin inhibition, and radiocontrast adminis- (RC) agents will often precipitate clinical ARF [1].tration was used. A computer-based simulation of oxygen ten-
An animal model emulating this type of human ARFsions along the nephron was utilized to interpret the findings.
was developed that includes uninephrectomy, salt re-Mechanistic studies were subsequently performed using oxy-
gen-sensitive electrodes and 31P nuclear magnetic resonance striction, volume depletion, prostaglandin inhibition, and
(NMR) spectroscopy to define the effect of RSR13 on renal RC administration [2]. In this model, serum creatinine
function in the setting of compromised acute renal failure. increases to nearly twice the normal concentrations in
Results. RSR13 did not attenuate acute renal failure in this 24 hours after RC administration and then slowly returns
model; rather, serum creatinine increased to a greater degree
to normal over the next three days. Pathological analysisin the RSR13-treated rats than in rats receiving saline vehicle
demonstrated necrosis of some cells in the thick as-as the control (P  0.05). Simulations explained this finding
cending limb (TAL) of the loop of Henle, and the sever-under conditions of severe medullary hypoxia. Mechanistic
studies demonstrated marked worsening of medullary hypoxia ity of this lesion correlated with the severity of renal
following RSR13 under conditions similar to our experimental dysfunction one day after RC administration. Worsening
model. Furosemide pretreatment to reduce the imbalance be- of medullary hypoxia is the postulated mechanism of the
tween oxygen supply and demand markedly attenuated the functional and morphological injuries in this model [2].basal-medullary hypoxia produced in the presence of indo-
RSR13, a synthetic allosteric modifier of hemoglobinmethacin and RSR13 (P 0.01). Additionally, 31P NMR studies
oxygen-binding affinity that increases the release of oxy-demonstrated renal adenosine 5-triphosphate (ATP) deple-
tion in rats with acute renal failure treated with RSR13 (45% gen from hemoglobin, has been developed and tested in
decrease, P 0.01); again, this effect of RSR13 was completely experimental models of impaired oxygen delivery [3–5].
prevented by pretreatment with furosemide. Because of this work and the link between acute renal
Conclusions. Under conditions of severe renal medullary failure and worsening of renal medullary hypoxia, we
hypoxia, induced in part by indomethacin-mediated reductions
hypothesized that the administration of RSR13, whichin outer medullary blood flow, the administration of RSR13
decreases the affinity of hemoglobin for oxygen, mightcan exacerbate acute renal dysfunction. However, reducing the
improve oxygen delivery to the renal medulla, attenuaterate of oxygen consumption by inhibiting sodium transport
with furosemide pretreatment or post-treatment appears to be the imbalance between oxygen supply and demand, and
functionally protective. delay or prevent acute renal failure in this model [6, 7].
This hypothesis was examined in the following studies.
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Inc. (Gilroy, CA, USA). At that facility, the animals On each of the next three days, 1.0 mL of blood was
withdrawn from the tail artery, and 24-hour urine sam-underwent a right nephrectomy at two months of age.
Following recovery, these otherwise healthy rats were ples were collected. On the third day, the rats were
weighed and given an overdose of sodium pentobarbital.delivered to the University of Colorado Health Sciences
Center (UCHSC) vivarium; they were housed two to a All blood and urine samples were analyzed on the same
day for sodium, potassium, creatinine, and urea nitrogen.cage for an additional four weeks prior to the start of
this study. At the time of study, the rats weighed between In this model, histological changes suggestive of a hy-
poxic injury (including cell swelling) were only seen at400 and 500 g. For the nuclear magnetic resonance (NMR)
studies, normal Sprague-Dawley rats weighing approxi- 24 hours after the combined insult. Since this was a three-
day study, histology was not examined.mately 150 to 200 g were used. NMR studies that were
performed could only be done with the available instru- Group 2: Effects of furosemide on acute renal failure.
Additional rats were treated with indomethacin plusmentation (vida infra) using small rats. Because of this
size constraint, NMR studies were performed on rats RSR13 (150 mg/kg, IP, N  6) or indomethacin, RSR13
and furosemide 8 mg/kg intravenously (IV; N  6) priorbearing two normal kidneys fed an ad libitum rat chow
diet. For the oxygen electrode studies, male Sprague- to radiocontrast. Another group received RSR13 (150
mg/kg, IP, N  6) alone prior to radiocontrast. In theseDawley rats (250 to 350 g body weight) were used.
rats, the urine output in the one hour after radiocontrast
Acute renal failure studies was monitored in a metabolic cage, and an equal volume
of 0.6% saline was administered via the femoral veinGroup 1: Effect of RSR13 on acute renal failure. To
assure that the volume depletion was achieved, furose- catheter. After one hour, the femoral vein catheter was
removed. The vein was ligated, and the incision wasmide was administered at a dose of 2 mg/kg (intraperito-
neally, IP) for four days followed by a seven-day period closed as in group 1. The rats were returned to the meta-
bolic cages to enable 24-hour urine collections per dayin which the rats were permitted to eat only boiled rice
as a food source. The combined effect of furosemide and over the next three days.
the low-sodium rice diet ensured sodium and volume
Mechanistic studiesdepletion [6]. All rats had free access to water throughout
the study. On the last day of rice consumption, each rat These studies were performed to test directly the hy-
pothesis that there were changes on pO2 in the outerwas placed in a metabolic cage to collect a 24-hour urine
sample. Subsequently, urine concentrations of creatinine, medulla under condition of our experiment and that such
changes would correlate with altered production of aden-urea nitrogen, sodium, and potassium were measured;
these data together with a plasma sample (discussed later osine triphosphate (ATP), an important component of
the oxygen supply-and-demand theory. High-energy phos-in this article) permitted calculation of baseline creati-
nine clearance and electrolyte excretion in each rat. phates were measured using 31P (phosphorous 31) NMR.
These NMR studies were performed using a 7.05 TeslaEach rat was weighed and given an intraperitoneal
injection of indomethacin (10 mg/kg). Forty-five minutes vertical bore cryomagnet with AM300 spectrometer
(Bruker Instruments, Billerica, MA, USA). Detection oflater, when kidney blood flow is known to be reduced
by indomethacin treatment, either RSR13 (150 mg/kg, the 31P signal was accomplished with a custom-fabricated,
two-turn surface coil of 8 mm diameter placed alongsideat 30 mg/mL in normal saline, N 6) or an equal volume
of saline vehicle (5 mL/kg, N  4) was administered by the greater curvature of the kidney after exposure with
a flank incision. A jugular vein was cannulated for drugintraperitoneal injection. Saline and RSR13 experiments
were conducted simultaneously. Fifteen minutes later, administration during these studies. The probe was tuned
to the frequency of 31P (121.5 MHz), and the animal wasanesthesia was induced by pentobarbital (35 mg/kg, IP),
and a small catheter was placed in the femoral vein. placed in a specially constructed plastic holder. The rat
and holder were placed in a vertical position within theBlood was subsequently withdrawn (0.8 mL) from this
catheter for analysis of serum creatinine and blood urea magnet. Following shimming on the proton signal, 31P
NMR spectra were acquired using a tip angle of 15 de-nitrogen, sodium, potassium, and hematocrit; then the
radiocontrast agent, sodium iothalamate [78%, Vas- grees (at the center of the coil), a relaxation delay of
0.051 seconds, and an array size of 1 K points. Fivecoray; Mallickrodt, Inc., St. Louis, MO, USA), was in-
jected over two minutes at a dose of 6 mL/kg. Ten min- minutes of acquisitions were averaged prior to exponen-
tial multiplication with 30 Hz line-broadening, Fourierutes later, the vascular catheter was withdrawn. The
vessel was ligated, and the groin incision was closed with transformation and phase correction. These spectral data
were then analyzed with an automated line-fitting pro-4-0 silk. All animals began to awaken within 30 minutes.
Rats breathed room air throughout this study. Fresh gram written in our laboratory [8]. An external standard
consisting of methylene diphosphonate in a capillarywater and normal rat chow were provided, and the rat
was returned to the metabolic cage. tube was used to correct for any changes in coil sensitivity
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that might occur during experiments. Tissue ATP con- minutes later, RSR13 (N  8) also was administered via
the jugular vein at a concentration of 30 mg/mL of 0.6%tent is presented as values relative to the value obtained
prior to any experimental manipulations. Intracellular saline solution for a dose of 150 mg/kg over several
minutes. In the furosemide experiments, 1.0 mL of warmpH values calculations based on the chemical shift of
inorganic phosphate were performed as reported pre- 0.6% saline was given intravenously at 15 minutes to
replace urine losses. OM pO2 values are reported asviously [9].
mean  SEM at 20 minutes after the completion of
Model of oxygen tensions along the nephron treatment with indomethacin, furosemide, saline, or
RSR13. After these values were obtained, mannitol wasOur previous study reported a model for renal oxygen
tensions that allows for computer simulation of the ef- given slowly as 2.0 mL of a 5% solution in distilled water,
which was approximately a 300 mOsm solution. OM pO2fects of altered renal blood flow, transport “work,” and
gas exchange between the descending and ascending was again recorded at 20 minutes after completing the
mannitol infusion.vasa rectae on renal oxygen and carbon dioxide tensions
[10]. For the purpose of this current study, we altered
Renal 31P NMR studiesthe original program to allow for manipulation of the
hemoglobin-oxygen-binding affinity curve. In the simula- Thirty minutes prior to placing the animal in the mag-
net, indomethacin (10 mg/mL in 100 mmol/L phosphate,tion program, this sigmoidal curve was generated by the
equation y z2/(z2 k2), where y is the oxygen saturation pH 8.0, 10 mg/kg) was added to the abdominal cavity
through an intraperitoneal catheter, as described pre-(O2 sat), z is the partial pressure of oxygen (pO2), and
k is that pO2 at which the hemoglobin is 50% saturated. viously in this article. In some experiments, furosemide
(N  8) was injected via the jugular vein catheter at aThis k is referred to in our article as the p50. The modifi-
cations to the previously published routine that runs in dose of 8 mg/kg at the same time as the indomethacin
was administered intraperitoneally. RSR13 (N  8) wasthe software package program Matlab (The MathWorks
Inc., Natick, MA, USA) were, therefore, limited to varia- given intravenously as 30 mg/mL of 0.6% saline solution,
150 mg/kg during acquisition of spectral data throughtions in the value of the p50.
the jugular venous catheter over several minutes.
Renal pO2 measurements
Statistical analysisRenal pO2 was measured using a needle electrode (No.
758-25; Diamond General Corp., Ann Arbor, MI, USA) Data were compared using one- or two-way analysis
of variance (ANOVA) and the unpaired or paired Stu-coupled to a microprocessor, as previously described
[4]. All data were visualized on the LED display of the dent t test with Scheffe’s correction for multiple compari-
sons, depending on the unpaired or paired nature ormicroprocessor and recorded on a PC for future analysis
by an investigator blinded to the treatment. Rats were the data [11]. Statistical analysis was performed using
SIGMASTAT Software (Jandel Scientific, Corte Mad-anesthetized with sodium pentobarbital (30 mg/kg). A
jugular vein catheter was inserted for delivery of infu- era, CA, USA).
sates or additional anesthesia, and the left kidney was
exposed and exteriorized through a flank incision. The
RESULTS
bladder was catheterized to collect urine.
Effects of kidney mass reduction andPartial pressure of oxygen (pO2) was measured under
volume depletioncontrol conditions with the oxygen electrode in the cor-
tex for two minutes at a depth of no more than 1 mm. All rats exhibited rather high hematocrit, as expected
from the combined furosemide and salt-restricted riceThen the electrode was advanced deeper into the kidney
parenchyma until an abrupt decrease in pO2 was noted; diet regimen, and the daily urine sodium and potassium
excretion rates were low. However, creatinine clearanceusually this occurred at 3 mm or deeper (depending on
the size of the kidney). This is an approximation of the and serum creatinine were normal, and there were no
differences in urine flow rate. Blood urea nitrogen (BUN)transition zone from cortex to medulla. The electrode
was then withdrawn approximately 50 , and this loca- values were clearly below those normally observed in
rats consuming conventional rat chow that was high intion was defined as the outer medulla (OM) [2]. After
three to five minutes of steady-state recording of pO2 in protein (Table 1).
the OM, one or more pharmacological agents were given
Effect of RSR13 or vehicle after radiocontrastas follows.
Indomethacin (10 mg/mL in 100 mmol/L phosphate, In vehicle-treated rats, there were no changes in creati-
nine clearance, serum creatinine, or BUN from pretreat-pH 8.0; 10 mg/kg) was added to the abdominal cavity.
Twenty minutes later, furosemide (N  8) was injected ment values over the three days following administration
of radiocontrast. This is likely due to the rather largevia the jugular vein catheter at a dose of 8 mg/kg. Twenty
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Table 1. Plasma and urinary characteristics prior to and following RSR13 (N6) or vehicle control (N4)
Post-treatment days
Baseline 1 2 3
Serum creatinine mg/dL
Control 0.600.06 0.520.02 0.580.02 0.450.03
RSR13 0.600.06 1.430.28bc 1.430.36bc 0.620.09
BUN mg/dL
Control 5.70.8 14.52.5a 16.70.8b 17.20.4b
RSR13 6.82.5 50.57.5bc 60.813.5bc 26.15.7b
FENa %
Control 0.350.01 0.150.04 0.500.09 0.280.04
RSR13 0.540.21 2.481.19bc 1.020.65bc 0.170.06
Creatinine clearance mL/min
Control 2.090.09 2.280.20 2.190.11 2.780.22
RSR13 2.130.17 0.810.20bc 1.080.30bc 2.220.28
Na excretion lEq/day
Control 17429 742162b 2296334b 1763332b
RSR13 26881 2250359bc 1001339bc 732151bc
Urine flow lL/min
Control 14.62.6 9.41.5 19.014.7 16.513.1
RSR13 12.61.1 15.20.7 15.03.8 15.87.1
Serum Na mEq/L
Control 1491.2 1480.9 1461.3 1441.5
RSR13 1490.9 1471.1 1450.7 1481.6
Serum K mEq/L
Control 4.60.6 4.40.2 4.90.3 4.00.1
RSR13 4.40.4 4.91.1 5.11.1 4.41.2
Hematocrit vol %
Control 50.62.3 — — 43.01.0b
RSR13 55.01.2 — — 44.73.6b
Values expressed as mean  SEM.
a P  0.05
b P  0.01 vs baseline
c P  0.05 vs. control
volume of saline given to match the volume of RSR13 Model of oxygen tensions along the nephron
solution. However, each rat given RSR13 exhibited a For the purposes of this simulation, blood flow was
transient elevation of serum creatinine and BUN and a allowed to vary; oxygen consumption was held constant
decrease in creatinine clearance. By the third day, renal at 8 mol/min, and the equilibrium constant for oxygen
function returned to pretreatment values in the RSR13- exchange was set at 1  106 mmol/min/torr as reported
treated group. Urine sodium excretion increased on the previously [10]. Our current report presents vasa rectae
blood flow rates ranging from 0.07 to 1.4, which probablyfirst day post-radiocontrast administration in both groups
covers the physiological range, but we ignored the com-of rats, but the increase was more pronounced in the
plex and considerable dependence that metabolic rateRSR13-treated animals. By the third day, urine sodium
has on the glomerular filtration rate that, in turn, is de-was greater in the vehicle-treated rats (Table 1).
pendent on blood flow (Figs. 2 and 3). When the p50
for hemoglobin is increased from 38 to 48 mm Hg (valuesEffect of furosemide on acute renal failure
reported in the absence and presence of RSR13) andAs noted in Table 1, RSR13 caused a transient increase
vasa rectae blood flow is high, our model predicts veryin serum creatinine and BUN and a significant decrease
high oxygen tensions in the medulla. This, in fact, isin creatinine clearance at day 1 in this model (all P 0.05;
what prompted us to undertake the study of a possible
serum creatinine and creatinine clearance data shown in beneficial effect in the acute renal failure model. How-
Fig. 1). In the RSR13 plus furosemide-treated group, ever, what is also apparent from Figure 2 is that at lower
the serum creatinine did not increase nor did creatinine blood flows where oxygen tensions fall to negligible val-
clearance decrease significantly at any time during the ues deep in the kidney, increasing the p50 from 38 to 48
three days of observation (Fig. 1). However, when the mm Hg results in the predicted pO2 values falling to
rats were exposed to RSR13 in the absence of indometh- zero at more superficial depths (that is, closer to the
acin, RSR13 treatment was not associated with an in- corticomedullary junction). In short, more of the kidney
crease in serum creatinine or decrease in creatinine clear- mass is exposed to anoxic conditions in this particular
situation.ance at any time (Fig. 1).
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Fig. 1. Serum creatinine and creatinine clearance prior to and following
radiocontrast administration in rats given RSR13 (in the presence of
indomethacin; ) or RSR13 (plus indomethacin) and furosemide ().
A third group of rats treated with RSR13 but not given indomethacin
pretreatment as part of the acute renal failure model also is shown ().
All groups have N  6; data are expressed as mean  SEM. *P  0.05
and **P  0.01 vs. baseline.
Fig. 2. Computer simulations depicting the relationship between depthReducing the metabolic activity of the thick ascending from the surface of the kidney, blood flow, and oxygen tension. For
limb transport segments of the nephron of the kidney by the purpose of this simulation, an exchange rate between ascending
and descending limbs of the vasa rectae of 1  106 mm Hg/mm/sec,80% (to simulate an effect of furosemide) raises oxygen
and a metabolic oxygen consumption rate of 8 mol/min were assumed.tensions dramatically throughout the nephron over the The simulations were performed assuming a hemoglobin p50 of 38 (A)
range of blood flows examined (Fig. 3). and 48 mm Hg (B).
Electrode pO2 measurements
6.1 mm Hg (P 0.01). The subsequent addition of man-
The direct measurements of oxygen tension were used nitol did not significantly change medullary pO2, averag-to confirm the predictions made by the modeling of this ing 38.1  6.0 mm Hg.
extremely complex vascular bed within the kidney. The RSR13 alone did not change the outer medullary pO2.
data show that in the anesthetized rat, oxygen tension Medullary pO2 averaged 10.1  2.0 mm Hg before
in the cortex was twofold higher than that in the outer RSR13 and 11.8 4.1 mm Hg at 20 minutes after RSR13.
medulla (Table 2). pO2 averaged 24.0  1.2 mm Hg in After mannitol injection, in these RSR13-treated rats,
the cortex and was quite similar among groups (Table 2). medullary pO2 remained constant, averaging 12.3 
Indomethacin treatment decreased medullary pO2 from 4.9 mm Hg. The vehicle for RSR13, namely saline,
11.2  1.4 to 2.5  0.6 mm Hg (P  0.01; Table 2). The caused no change in medullary pO2, which averaged
effect of a subsequent injection of mannitol in these 11.3  4.0 mm Hg before saline and 11.7  4.4 mm Hg
animals was not examined. Furosemide resulted in an after saline. Subsequent addition of mannitol did not
alter medullary pO2, which averaged 9.3  4.2 mm Hg.increase in medullary pO2 from 14.6  2.5 to 37.0 
Burke et al: Effects of RSR13 on acute renal failure1412
Fig. 4. 31P NMR spectroscopic measurements of inorganic phosphate
(Pi, A) and adenosine 5-triphosphate (ATP; B) concentrations follow-
ing administration of RSR13 after pretreatment with indomethacin
alone (, N  8) or indomethacin  furosemide (, N  8). Data are
expressed as fraction of baseline and shown as mean  SEM. *P 
0.05 and **P  0.01 vs. RSR13 following indomethacin alone.
Fig. 3. Computer simulations depicting the relationship between depth Renal 31P NMR studies
from the surface of the kidney, blood flow and oxygen tension under
In the rats given indomethacin followed by RSR13,the influence of furosemide. For the purpose of this simulation, the
metabolic rate of the inner half (by depth, not volume) of the kidney the inorganic phosphate (Pi) concentration doubled. Fu-
was reduced by 80%. Otherwise, the simulations were performed as rosemide prevented this change in Pi (Fig. 4A). Renaldescribed in Figure 2 assuming a hemoglobin p50 of either 38 (A) or
ATP content decreased by 40% following the infusion of48 mm Hg (B).
RSR13 in indomethacin-pretreated rats (Fig. 4B). When
rats were given indomethacin followed by furosemide
and then RSR13, there was no fall in ATP content (Fig.Table 2. Partial pressure of oxygen (pO2) in renal cortex and outer
4B). A significant decrease of intracellular pH (pHi) ac-medulla (OM), effects of indomethacin, furosemide, or RSR13
companied the decreases in ATP and increases in Pi inBaseline OM
the RSR13 plus indomethacin-treated rats (6.71  0.08
N Cortex OM drug Mannitol
at 50 min vs. 7.26  0.04 at baseline, P  0.01), and
Indomethacin 8 24.01.2 11.21.4 2.50.6a ND furosemide treatment prevented this decrease.Furosemide 8 25.01.9 14.62.5 37.06.1a 38.16.0
Salineb 8 29.01.9 11.34.0 11.74.4 9.34.2
RSR13 8 24.02.4 10.12.0 11.84.1 12.34.9c
DISCUSSIONData are presented in torr and shown as mean  SEM.
a P  0.01 vs. baseline outer medulla This study employed a model of acute renal failureb Saline is the vehicle for RSR13 experiments
c N  3 experiments, ND is not determined that is believed to mimic human acute renal failure and
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has medullary hypoxia as its primary pathophysiological shunting of well-oxygenated blood from the descending
to ascending vasa rectae in the setting of very low vasadisturbance [6]. We originally hypothesized that, by “un-
loading” oxygen bound to hemoglobin, RSR13 would rectae blood flow induced by indomethacin.
No attempt was made to measure oxygen tensionsimprove renal function in this model because tubular
hypoxia is a hallmark of functional and morphologic under these combined conditions because the spatial lim-
itations of the oxygen electrodes would not allow usinjury. However, precisely the opposite effect was found:
RSR13-treated rats developed a transient, short-lived, to confirm or refute this hypothesis. However, further
support for this concept was provided with the 31P NMRreversible renal dysfunction, whereas the control group
given saline vehicle did not develop acute renal dysfunc- studies that demonstrated very significant falls in ATP
concentrations with reciprocal increases in inorganic phos-tion. We hypothesize that the reason for the lack of
acute renal failure in the saline vehicle-treated group phate concentrations (reflecting tissue hypoxia and an ac-
companying intracellular acidosis) following RSR13 ad-was related to volume expansion. Heyman et al have
shown that acute volume expansion prevents the devel- ministration after the administration of indomethacin.
It is important to note that when RSR13 was adminis-opment of ARF in an identical model [2]. The addition
of approximately 2.5 mL of isotonic saline alone to the tered in the absence of indomethacin, there was essen-
tially no deleterious effect on renal function noted (Fig. 1).peritoneal cavity, which matched the volume of the
RSR13 solution, was necessitated by the solubility char- Clearly, if there is not concomitant reduction of blood
flow, as occurs with indomethacin, RSR13 would not beacteristics of RSR13 [4]. Volume expansion or repletion
is known to delay or attenuate the ischemic renal failure expected to be injurious to kidney function.
Through an appreciation of the unique vascular anat-in both experimental animals and susceptible patients
exposed to contrast agents [12]. omy of the kidney and its role in the determination of
gas tensions along the nephron, it appears that one couldNot only did creatinine clearance decrease in the
RSR13-treated rats, but serum creatinine, BUN, and develop maneuvers by which the effects of RSR13 could
be mitigated or minimized. The most attractive approachfractional excretion of sodium (FENa) increased. These
measurements are an indication of acute tubular dys- may reduce energy needs (and the imbalance between
oxygen availability and energy consumption) by reduc-function characteristic of reversible ischemic acute renal
failure [13]. All renal parameters in the RSR13-treated ing “active” transport in the mTAL with a loop diuretic
such as furosemide. A furosemide treatment-induced in-rats returned to normal by the third day after radiocon-
trast exposure. crease in medullary pO2 has been convincingly demon-
strated in rats as well as more recently in humans [2,One explanation for this rather unexpected kidney
response to RSR13, as compared with all other tissues, 14–16]. The current study also demonstrated this effect of
furosemide. Returning to the acute renal failure model,is that oxygen was released from hemoglobin in the most
proximal portions of the outer medulla (the early portion furosemide substantially attenuated the transient renal
dysfunction produced by RSR13. Similarly, whereasof the descending vasa rectae), leading to a large de-
crease in pO2 in the deeper nephron regions of the kid- RSR13 on the background of prostaglandin inhibition
caused significant depletion of ATP, furosemide pre-ney. Such an effect would widen the difference between
oxygen supply and demand (for transport-associated en- treatment completely prevented the ATP depletion.
Our findings are of interest for several reasons. Onergy needs).
To confirm this hypothesis, direct measurements of the theoretical side, the observations offer additional
validation for the medullary hypoxia concept which wasoxygen tension were utilized at various sites within the
kidney, as well as simulations that we had previously proposed by Epstein and colleagues in the mid-1980s
[1], and they support the utility of using our simple modeldeveloped to predict gas tensions along the nephron.
Based on the simulations, RSR13 would be expected of gas exchange along the nephron to predict pathophysi-
ological events. On a more practical note, the ultimateto increase, not decrease, local oxygen tensions if the
vasa rectae blood flow remained high. However, if blood utility of RSR13 as a clinical agent to improve tissue
oxygenation in other organs requires that effects on renalflow through the vasa rectae was substantially reduced
(as might be expected after indomethacin administration function be avoided. The clinical circumstances of hypo-
perfusion and shock where RSR13 could have great ofand/or salt depletion), RSR13 was predicted to increase
the amount of kidney tissue exposed to anoxia (Fig. 2). utility in improving tissue oxygenation in the cardiac and
cerebral vascular beds [4, 5], therefore, are circumstancesOur mechanistic studies found that the administration
of indomethacin reduced the medullary pO2 to essen- in which renal dysfunction also might occur. It is interest-
ing to note that transient renal dysfunction was recentlytially zero (Table 2) even without pre-existing sodium
depletion and radiocontrast administration. We believe reported in several patients undergoing general surgery
who had received RSR13 [17]. We suggest that the sur-that this strongly supports the concept that the renal
dysfunction in this model is due to RSR13-enhanced gery and/or attendant anesthesia might have decreased
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3. Khandelwal SR, Kavanagh BD, Lin PS, et al: RSR13, an alloste-renal blood flow, making these subjects more susceptible
ric effector of haemoglobin, and carbogen radiosensitize FSAII
to RSR13-induced renal anoxia. Our data suggest that and SCCVII tumours in C3H mice. Br J Cancer 79:814–820, 1999
4. Kilgore KS, Shwartz CF, Gallagher MA, et al: RSR13, a syn-co-administration of RSR13 and furosemide (with close
thetic allosteric modifier of hemoglobin, improves myocardial re-attention to preventing diuretic-induced volume deple-
covery following hypothermic cardiopulmonary bypass. Circula-
tion) in situations in which renal hypoperfusion is likely tion 100:II351–II356, 1999
5. Sarraf-Yazdi S, Sheng H, Grocott HP, et al: Effects of RSR13,to be a comorbid event would prevent or substantially
a synthetic allosteric modifier of hemoglobin, alone and in combi-attenuate transient renal dysfunction.
nation with dizocilpine, on outcome from transient focal cerebral
In summary, RSR13 administered in the setting of ischemia in the rat. Brain Res 826:172–180, 1999
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